Johnson & Johnson (NYSE:JNJ) went up by 0.63% from its latest closing price when compared to the 1-year high value of $148.99 and move down -13.42%, while JNJ stocks collected -0.51% of loss with the last five trading sessions.
Johnson & Johnson (NYSE:JNJ) Worth an Investment?
Johnson & Johnson (NYSE: JNJ) scored price to earnings ratio above its average ratio, recording 21.78 times of increase in earnings at the present.
JNJ Market Performance
JNJ stocks went down by -0.51% for the week, with the monthly drop of -0.54% and a quarterly performance of -5.23%, while its annual performance rate touched 0.71%. The simple moving average for the period of the last 20 days is 0.39% for JNJ stocks with the simple moving average of -3.86% for the last 200 days.
Analysts’ Opinion on Johnson & Johnson (NYSE:JNJ)
Many brokerage firms have already submitted their reports for JNJ stocks, with Credit Suisse repeating the rating for JNJ shares by setting it to “Outperform”. The predicted price for JNJ socks in the upcoming period according to Credit Suisse is $156 based on the research report published on July 12, 2019.
Goldman, on the other hand, stated in their research note that they expect to see JNJ stock at the price of $156. The rating they have provided for JNJ stocks is “Buy” according to the report published on May 28, 2019.
Barclays gave “Equal Weight” rating to JNJ stocks, setting the target price at $135 in the report published on January 23, 2019.
JNJ Stocks -3.39% Far from 50 Day Moving Average
After a stumble in the market that brought JNJ to its low price for the period of the last 52 weeks, Johnson & Johnson was unable to take a rebound, for now settling with -11.83% of loss for the given period.
The stock volatility was left at 1.40%, however, within the period of a single month, the volatility rate increased by 1.35%, while the shares surge at the distance of +0.81% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -3.89% lower at the present time.
In the course of the last 5 trading sessions, JNJ went down by -0.51%, which changed the moving average for the period of 200 days to the total of -4.50% of losses for the stock in comparison to the 20-day moving average settled at $130.91. In addition, Johnson & Johnson saw 1.79% in overturn over the period of a single year with a tendency to cut further gains.
JNJ Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Johnson & Johnson (JNJ), starting from HEWSON MARILLYN A, who bought 3,000 shares at the price of $139.68 back on Jun 11. After this action, Rushing now owns 3,000 shares of Johnson & Johnson, valued at $419,040 with the latest closing price.
PRINCE CHARLES, the Director of Johnson & Johnson, bought 2,000 shares at the value of $134.37 during a trade that took place back on Dec 14, which means that PRINCE CHARLES is holding 28,520 shares at the value of $268,731 based on the most recent closing price.
JNJ Stock Fundamentals
The current profitability levels are settled at +26.07 for the present operating margin and +66.66 for gross margin. The net margin for Johnson & Johnson stands at +18.76. Total capital return value is set at 22.98, while invested capital returns managed to touch 17.16. Equity return holds the value 26.80%, with 10.60% for asset returns.
Based on Johnson & Johnson (JNJ), the company’s capital structure generated 51.01 points for debt to equity in total, while total debt to capital is set at the value of 33.78. Total debt to assets is settled at the value of 19.93 with long-term debt to equity ratio rests at 46.33 and long-term debt to capital is 30.68.
EBITDA value lies at +7.10 B with total debt to EBITDA carrying the value of 1.08. The value for Enterprise to Sales is 4.42 with debt to enterprise value settled at 0.09. The receivables turnover for Johnson & Johnson is 5.91 with the total asset turnover at the value of 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.47.